Literature DB >> 18271520

Discovery of kinase inhibitors by high-throughput docking and scoring based on a transferable linear interaction energy model.

Peter Kolb1, Danzhi Huang, Fabian Dey, Amedeo Caflisch.   

Abstract

The linear interaction energy method with continuum electrostatics (LIECE) is evaluated in depth on five kinases. The two multiplicative coefficients for the van der Waals energy and electrostatic free energy are shown to be transferable among different kinases. Moreover, good enrichment factors are obtained for a library of 40375 diverse compounds seeded with 73 known inhibitors of CDK2. Therefore, a general two-parameter LIECE model for kinases is derived by combining large data sets of inhibitors of CDK2, Lck, and p38. This two-parameter model is cross-validated on two kinases not used for fitting; it shows an average error of about 1.5 kcal/mol for the prediction of absolute binding affinity of 37 and 128 known inhibitors of EphB4 and EGFR, respectively. High-throughput docking and ranking by two-parameter LIECE models are shown to be able to identify novel low-micromolar EphB4 and CDK2 inhibitors of low-molecular weight (< or =355 g/mol).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18271520     DOI: 10.1021/jm070654j

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  13 in total

1.  Chemical space sampling by different scoring functions and crystal structures.

Authors:  Natasja Brooijmans; Christine Humblet
Journal:  J Comput Aided Mol Des       Date:  2010-04-18       Impact factor: 3.686

2.  Molecular dynamics simulation and linear interaction energy study of D-Glu-based inhibitors of the MurD ligase.

Authors:  Andrej Perdih; Gerhard Wolber; Tom Solmajer
Journal:  J Comput Aided Mol Des       Date:  2013-08-30       Impact factor: 3.686

3.  Screening of benzamidine-based thrombin inhibitors via a linear interaction energy in continuum electrostatics model.

Authors:  Orazio Nicolotti; Ilenia Giangreco; Teresa Fabiola Miscioscia; Marino Convertino; Francesco Leonetti; Leonardo Pisani; Angelo Carotti
Journal:  J Comput Aided Mol Des       Date:  2010-02-11       Impact factor: 3.686

4.  Evaluation of several two-step scoring functions based on linear interaction energy, effective ligand size, and empirical pair potentials for prediction of protein-ligand binding geometry and free energy.

Authors:  Obaidur Rahaman; Trilce P Estrada; Douglas J Doren; Michela Taufer; Charles L Brooks; Roger S Armen
Journal:  J Chem Inf Model       Date:  2011-06-06       Impact factor: 4.956

5.  An Evaluation of Explicit Receptor Flexibility in Molecular Docking Using Molecular Dynamics and Torsion Angle Molecular Dynamics.

Authors:  Roger S Armen; Jianhan Chen; Charles L Brooks
Journal:  J Chem Theory Comput       Date:  2009-10-13       Impact factor: 6.006

6.  Automated site preparation in physics-based rescoring of receptor ligand complexes.

Authors:  Chaya S Rapp; Cheryl Schonbrun; Matthew P Jacobson; Chakrapani Kalyanaraman; Niu Huang
Journal:  Proteins       Date:  2009-10

7.  A double-headed cathepsin B inhibitor devoid of warhead.

Authors:  Patricia Schenker; Pietro Alfarano; Peter Kolb; Amedeo Caflisch; Antonio Baici
Journal:  Protein Sci       Date:  2008-09-16       Impact factor: 6.725

8.  Binding free energy calculations of N-sulphonyl-glutamic acid inhibitors of MurD ligase.

Authors:  Andrej Perdih; Urban Bren; Tom Solmajer
Journal:  J Mol Model       Date:  2009-02-06       Impact factor: 1.810

9.  Hydrogen bonding penalty upon ligand binding.

Authors:  Hongtao Zhao; Danzhi Huang
Journal:  PLoS One       Date:  2011-06-17       Impact factor: 3.240

10.  Discovery of a non-peptidic inhibitor of west nile virus NS3 protease by high-throughput docking.

Authors:  Dariusz Ekonomiuk; Xun-Cheng Su; Kiyoshi Ozawa; Christophe Bodenreider; Siew Pheng Lim; Zheng Yin; Thomas H Keller; David Beer; Viral Patel; Gottfried Otting; Amedeo Caflisch; Danzhi Huang
Journal:  PLoS Negl Trop Dis       Date:  2009-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.